Subscribe to RSS
DOI: 10.1055/s-2003-44974
Zn(ClO4)2·6H2O as a Powerful Catalyst for the Conversion of β-Ketoesters into β-Enamino Esters
Publication History
Publication Date:
04 December 2003 (online)

Abstract
Zn(ClO4)2·6H2O proved to be a very powerful catalyst for the condensation of primary and secondary amines with β-ketoesters to give N-substituted β-enaminoesters.
Key words
amino acid derivatives - zinc perchlorate - condensation - amines - keto esters
- 1a
Tomioka K.Ando K.Takemasa Y.Koga K. J. Am. Chem. Soc. 1984, 106: 2718 - 1b
Georg GI.Guan X.Kant J. Tetrahedron Lett. 1988, 29: 403 - 1c
Felice E.Fioravanti S.Pellacani L.Tardella PA. Tetrahedron Lett. 1999, 40: 4413 - 2a
Lubell WD.Kitamura M.Noyori R. Tetrahedron: Asymmetry 1991, 2: 543 - 2b
Bartoli G.Cimarelli C.Marcantoni E.Palmieri G.Petrini M. J. Org. Chem. 1994, 59: 5328 - 2c
Palmieri G.Cimarelli C. J. Org. Chem. 1996, 61: 5557 - 2d
Potin D.Dumas F.d’Angelo J. J. Am. Chem. Soc. 1990, 112: 3483 - 2e
Cimarelli C.Palmieri G.Volpini E. Synth. Commun. 2001, 31: 2943 - 3a
Paulvannan K.Stille JR. J. Org. Chem. 1994, 59: 1613 - 3b
Barta NS.Brode A.Stille JR. J. Am. Chem. Soc. 1994, 116: 6201 - 3c
Cook GR.Beholz LG.Stille JR. J. Org.Chem. 1994, 59: 3575 - 3d
Hong CY.Kishi Y. J. Am. Chem. Soc. 1992, 114: 7001 - 3e
Blot J.Bardou A.Bellec C.Fargeau-Bellassoued M.-C.Célérier JP.Lhommet G.Gardette D.Gramain J.-C. Tetrahedron Lett. 1997, 38: 8511 - 3f
Michael JP.de Koning CB.Gravestock D.Hosken GD.Howard AS.Jungmann CM.Krause RWM.Parsons AS.Pelly SC.Stanbury TV. Pure Appl. Chem. 1999, 71: 979 - 3g
Hernandez A.Marcos M.Rapoport H. J. Org. Chem. 1995, 60: 2683 - 3h
David O.Blot J.Bellec C.Fargeau-Bellassoued M.-C.Haviari G.Célérier JP.Lhommet G.Gramain J.-C.Gardette D. J. Org. Chem. 1999, 64: 3122 - 3i
Michael JP.Parsons AS. Tetrahedron 1999, 55: 10915 - 4
Beholz LG.Benovsky P.Ward DL.Barta NS.Stille JR. J. Org. Chem. 1997, 62: 1033 - 5a
Elassar A.-ZA.El-Khair AA. Tetrahedron 2003, 59: 8463 - 5b
Agami C.Dechoux L.Hebbe S. Tetrahedron Lett. 2002, 43: 2521 - 5c
Stefani HA.de Avila E. Synth. Commun. 2002, 32: 2041 - 5d
Ferraz HMC.Pereira FLC.Leite FS.Nunes MRS.Payret-Arrua ME. Tetrahedron 1999, 55: 10915 - 5e
Trautwein AW.Jung G. Tetrahedron Lett. 1998, 39: 8263 - 5f
Erian AW. J. Prakt. Chem. 1999, 341: 147 - 5g
Daley V.d’Angelo J.Cavé C.Mahuteau J.Chiaroni A.Riche C. Tetrahedron Lett. 1999, 40: 1657 - 5h
d’Angelo J.Cavé C.Desmaele D.Gassama A.Thominiaux C.Riche C. Heterocycles 1998, 47: 725 - 6a
Hannick SM.Kishi Y. J. Org. Chem. 1983, 48: 3833 - 6b
Lee AS.-Y.Cheng R.-Y. Tetrahedron Lett. 1997, 38: 443 - 6c
Bird TGC.Olivier A. Bioorg. Med. Chem. Lett. 1996, 6: 515 - 7a
Fukuyama T.Yung YM. Tetrahedron Lett. 1981, 22: 3760 - 7b
Jiang N.Qu Z.Wang J. Org. Lett. 2001, 3: 2989 - 8a
Uneyama K.Morimoto O.Yamashita F. Tetrahedron Lett. 1989, 30: 4821 - 8b
Fustero S.Pina B.Simón-Fuentes A. Tetrahedron Lett. 1997, 38: 6771 - 8c
Fustero S.Pina B.Salavert E.Navarro A.Ramirez de Arellano MC.Simón-Fuentes A. J. Org. Chem. 2002, 67: 4667 - 8d
Fustero S.Pina B.García de la Torre M.Navarro A.Ramirez de Arellano MC.Simón A. Org. Lett. 1999, 1: 977 - 9a
Bartoli G.Cimarelli C.Dalpozzo R.Palmieri G. Tetrahedron 1995, 51: 8613 - 9b
Katritzky AR.Fang Y.Donkor A.Xu J. Synthesis 2000, 2029 - 10
Fustero S.García del la Torre M.Jofrè V.Pérez Carlon R.Navarro A.Simón Fuentes A. J. Org. Chem. 1998, 63: 8825 - 11a
Ferraz HMC.Oliveira EO.Payret-Arrua ME.Brandt CA. J. Org. Chem. 1995, 60: 7357 - 11b
Kloek JA.Leschinsky KL. J. Org. Chem. 1978, 43: 1460 - 11c
Soloshonok VA.Kukhar V. Tetrahedron 1996, 52: 6953 - 11d
Leflemme N.Dallemagne P.Rault S. Synthesis 2002, 1740 - 11e
Calvet S.David O.Vanucci-Bacqué Fargeau-Bellassoued M.-C.Lhommet G. Tetrahedron 2003, 59: 6333 - 12
Bartoli G.Bosco M.Marcantoni E.Massaccesi M.Rinaldi S.Sambri L. Tetrahedron Lett. 2002, 34: 6331 - 13
Bartoli G.Bosco M.Dalpozzo R.Marcantoni E.Massaccesi M.Rinaldi S.Sambri L. Synlett 2003, 39 - 14a
Schumacher JC. Perchlorates - their Properties, Manufacture and Uses ACS Monograph Series, Reinhold; New York: 1960. - 14b
Long J. Chem. Health Saf. 2002, 9: 12 - 15
Bartoli G.Bosco M.Dalpozzo R.Marcantoni E.Massaccesi M.Sambri L. Eur. J. Org. Chem. 2003, 6: 4611 - 18
Chakraborti AK.Sharma L.Gulhane R. . Tetrahedron 2003, 59: 7661 - 19a
Filyakova VI.Karpenko NS.Kuznetsova OA.Pashkevich KI. Russ. J. Org. Chem. 1998, 34: 381 - 19b
We confirmed the structure of 5d with NOE NMR experiments.
- 20
Katsuyama I.Ogawa S.Yamaguchi Y.Funabiki K.Matsui M.Muramatsu H.Shibata K. Synthesis 1997, 1321 - 21
Naringrekar VH.Stella VJ. J. Pharm. Sci. 1990, 79: 138 - 22
Fretz H.Gaugler M.Schneider J. Helv. Chim. Acta 2000, 83: 1145 - 23
Sugita T.Eida M.Ito H.Komatsu N.Abe K.Suamapp M. J. Org. Chem. 1987, 52: 3789
References
These conditions are sufficient to reactivate the catalyst, without any decomposition process. Zn(ClO4)2·6H2O in fact decomposes under vacuum at temperatures higher than 140 °C.
17
Representative Experimental Procedure: Synthesis of tert-butyl-3-anilino-2-butenoate (1a). To a round-bottom flask Zn(ClO4)2·6H2O (24 mg, 0.063 mmol), MgSO4 (46 mg, 0.38 mmol), t-butyl acetoacetate (0.21 mL, 1.26 mmol), CH2Cl2 (0.5 mL) and aniline (0.17 mL, 1.90 mmol) were added. The reaction mixture was stirred
at r.t. for 21 h. After addition of 5 mL of CH2Cl2, the catalyst was filtered off and the solution was concentrated at reduced pressure.
The crude product was purified by filtration on a short silica gel column pre-treated
with Et3N. The filtered catalyst was reactivated by heating in a oven at 60 °C overnight and
reused. Compounds 5a, 5b and 5e are commercial products. 1f,
[21]
1h,
[21]
1o,
[22]
5c
[23]
and 5d
[19]
are known compounds. Spectroscopic data for selected examples follow.
t
-Butyl (
Z
)-3-anilino-2-butenoate (
1a): 1H NMR (300 MHz, CDCl3): δ = 1.50 (s, 9 H, 3 × CH3), 1.97 (s, 3 H, CH3), 4.60 (bs, 1 H, CH), 7.05-7.20 (m, 3 H, Ph), 7.25-7.35 (m, 2 H, Ph), 10.40 (bs,
1 H, NH). 13C NMR (75 MHz, CDCl3):
δ = 20.2 (CH3), 28.6 (CH3), 78.5 (C), 87.8 (CH), 124.2 (CH), 124.6 (CH), 128.9 (CH), 139.5 (C), 158.0 (C),
170.3 (C). IR (nujol): νNH = 3272 cm-1. MS (EI): m/z (%) = 233(6) [M+], 17 7(16), 118 (41), 77 (30), 59 (100).
Ethyl (
Z
)-2-(butylamino)-1-cyclopentene-1-carboxylate (
1g): 1H NMR (300 MHz, CDCl3): δ = 0.93 (t, 3 H, CH3, J
HH = 7.2 Hz), 1.27 (t, 3 H, CH3, J
HH = 7.2 Hz), 1.35-1.40 (m, 2 H, CH2), 1.45-1.60 (m, 2 H, CH2), 1.80-1.90 (m, 2 H, CH2), 2.45-2.60 (m, 4 H, 2 × CH2), 3.15-3.25 (m, 2 H, CH2), 4.13 (q, 2 H, CH2, J
HH = 7.2 Hz), 7.40 (bs, 1 H, NH).
13C NMR (75 MHz, CDCl3) δ = 13.6 (CH3), 14.7 (CH3), 19.8 (CH2), 20.8 (CH2), 28.9 (CH2), 31.9 (CH2), 32.9 (CH2), 44.2 (CH2), 58.2 (CH2), 91.9 (C), 164.8 (C), 168.4 (C). IR (neat): νNH = 3320 cm-1. MS (EI): m/z (%) = 211 (43) [M+], 182 (9), 166 (28), 122 (100).